Do you want to skip to content? Skip to content
Convatec Group Contact Us България България Bosna i Hercegovina Bosna i Hercegovina Česko Česko Danmark Danmark Österreich Österreich Schweiz (Deutsch) Schweiz (Deutsch) Deutschland Deutschland Ελλάδα Ελλάδα United Kingdom United Kingdom Ireland Ireland España España Eesti Eesti Suomi Suomi Suisse (Français) Suisse (Français) France France Hrvatska Hrvatska Magyarország Magyarország Ísland Ísland Italia Italia Lietuva Lietuva Latvija Latvija Северна Македонија Северна Македонија Malta Malta Norge Norge België België Nederland Nederland Polska Polska Portugal Portugal România România Slovensko Slovensko Slovenija Slovenija Srbija Srbija Sverige Sverige Türkiye Türkiye Україна Україна Brasil Brasil United States (English) United States (English) Estados Unidos (Español) Estados Unidos (Español) Argentina Argentina Canada (English) Canada (English) Canada (Français) Canada (Français) Chile Chile Colombia Colombia Ecuador Ecuador México México Perú Perú Belize Belize Guyana Guyana Jamaica Jamaica Venezuela Venezuela Costa Rica Costa Rica Curaçao Curaçao República Dominicana República Dominicana Guatemala Guatemala Honduras Honduras Nicaragua Nicaragua Panamá Panamá Puerto Rico Puerto Rico Suriname Suriname El Salvador El Salvador الإمارات العربية المتحدة الإمارات العربية المتحدة البحرين البحرين مصر مصر ישראל ישראל ایران ایران الأردن الأردن عُمان عُمان قطر قطر پاکستان پاکستان لبنان لبنان الكويت الكويت المملكة العربية السعودية المملكة العربية السعودية Suid-Afrika Suid-Afrika العراق العراق New Zealand New Zealand 日本 日本 Australia Australia India India Malaysia Malaysia Singapore Singapore 대한민국 대한민국 中国大陆 中国大陆 中国台湾 中国台湾 ไทย ไทย Indonesia Indonesia Việt Nam Việt Nam Philippines Philippines Hong Kong SAR China (English) Hong Kong SAR China (English) 中国香港特别行政区 (中文(简体,中国香港特别行政区)) 中国香港特别行政区 (中文(简体,中国香港特别行政区))
False /oidc-signin/en-us/ Convatec Group Contact Us България България Bosna i Hercegovina Bosna i Hercegovina Česko Česko Danmark Danmark Österreich Österreich Schweiz (Deutsch) Schweiz (Deutsch) Deutschland Deutschland Ελλάδα Ελλάδα United Kingdom United Kingdom Ireland Ireland España España Eesti Eesti Suomi Suomi Suisse (Français) Suisse (Français) France France Hrvatska Hrvatska Magyarország Magyarország Ísland Ísland Italia Italia Lietuva Lietuva Latvija Latvija Северна Македонија Северна Македонија Malta Malta Norge Norge België België Nederland Nederland Polska Polska Portugal Portugal România România Slovensko Slovensko Slovenija Slovenija Srbija Srbija Sverige Sverige Türkiye Türkiye Україна Україна Brasil Brasil United States (English) United States (English) Estados Unidos (Español) Estados Unidos (Español) Argentina Argentina Canada (English) Canada (English) Canada (Français) Canada (Français) Chile Chile Colombia Colombia Ecuador Ecuador México México Perú Perú Belize Belize Guyana Guyana Jamaica Jamaica Venezuela Venezuela Costa Rica Costa Rica Curaçao Curaçao República Dominicana República Dominicana Guatemala Guatemala Honduras Honduras Nicaragua Nicaragua Panamá Panamá Puerto Rico Puerto Rico Suriname Suriname El Salvador El Salvador الإمارات العربية المتحدة الإمارات العربية المتحدة البحرين البحرين مصر مصر ישראל ישראל ایران ایران الأردن الأردن عُمان عُمان قطر قطر پاکستان پاکستان لبنان لبنان الكويت الكويت المملكة العربية السعودية المملكة العربية السعودية Suid-Afrika Suid-Afrika العراق العراق New Zealand New Zealand 日本 日本 Australia Australia India India Malaysia Malaysia Singapore Singapore 대한민국 대한민국 中国大陆 中国大陆 中国台湾 中国台湾 ไทย ไทย Indonesia Indonesia Việt Nam Việt Nam Philippines Philippines Hong Kong SAR China (English) Hong Kong SAR China (English) 中国香港特别行政区 (中文(简体,中国香港特别行政区)) 中国香港特别行政区 (中文(简体,中国香港特别行政区))
a woman with her hands up ;

Infusion care for diabetes

Serving people with diabetes by providing innovative subcutaneous treatment solutions.

What is diabetes?

Diabetes is a chronic condition where the body cannot regulate blood sugar levels properly. This happens when the pancreas can no longer make insulin, or the body cannot effectively use insulin. Insulin is a crucial hormone that enables sugar from the blood to enter cells,
providing cells with energy. Without sufficient insulin, blood sugar levels remain high which can result in serious health problems.

For patients with type 1 diabetes, the pancreas does not produce insulin or very little insulin, whereas the main indicator of type 2 diabetes is insulin resistance, meaning that the body cannot fully respond to insulin.

While type 1 diabetes can currently not be cured or prevented, type 2 diabetes can in many cases be prevented or delayed.1, 2, 3, 4, 5, 6
Symptoms a man sitting on a couch ;

Symptoms

Symptoms of diabetes can include:7, 8

  • Increased thirst and urination
  • Increased hunger
  • Fatigue
  • Blurred vision
  • Numbness or tingling in the feet or hands
  • Sores that do not heal
  • Unexplained weight loss
Treatment a man looking at a phone ;

Treatment and management of type 1 diabetes

Although there is currently no answer to what triggers type 1 diabetes or how to prevent it, the condition can be treated effectively. Treatment for diabetes varies between different people. Since a lack of insulin production is the factor causing type 1 diabetes, treatment for it involves administering insulin via injection or a pump. Patients also need to monitor their blood glucose levels frequently to ensure they remain within a target range. It is important to balance insulin doses with food intake and physical activity. The personalised treatment and management plan for each patient is determined and discussed during regular consultations with healthcare professionals.2,9

Treatment and management of type 2 diabetes

While treatment for type 2 diabetes also varies between people, maintaining a healthy lifestyle, including a balanced diet, increased physical activity, and a healthy body weight is central to type 2 diabetes management. Over time, oral medication may be necessary to keep blood sugar levels under control. When oral medication is not enough to control blood sugar levels, people living with type 2 diabetes may require insulin treatment.6

Insulin pump therapy a white cord plugged into a wall ;

Convatec infusion sets for insulin pump therapy

Providing insulin to people can be done via continuous subcutaneous insulin infusion (CSII). CSII involves an insulin pump to deliver insulin into the subcutaneous layer underneath the skin.10 At Convatec Infusion Care, we have over 30 years of experience developing innovative infusion sets to be used for CSII.

Our product range diagram ;

Our product range

Being a global leader11 in infusion set design, development, and manufacturing, we supply infusion sets to many of the world's leading insulin pump manufacturers. Our diabetes product range features both steel needle and soft cannula infusion sets for manual insertion as well as soft cannula infusion sets with an integrated insertion device. 

See our product overview

Our partners

To serve people living with diabetes, we work in close collaboration with our trusted B2B partners. We support our partners with both purchasing of our Convatec product range with their own private label as well as with manufacturing their own designed and branded products.

Guidance on using our products

Our infusion sets are designed with ease of use in mind, but it is important to follow the advice of healthcare professionals and consult the instructions for use when using an infusion set.

Below you can find supporting resources that can help when using our infusion sets. Please note that these user guides do not replace consulting a healthcare professional or the instructions for use that come with the infusion sets.

User guides a person playing video games with a remote control ;

Our vision

Pioneering
trusted medical solutions
to improve the lives we touch

Get in touch with Convatec Infusion Care

Contact us

AP number 
AP-72490-GBL-ENG-v1

Trademarks
The Convatec name, Hug icon, and strapline are trademarks of Convatec. ™/® refer to trademarks of the Convatec group of companies. Where we refer to the products distributed by our partners, ™/® refer to trademarks owned by them.

References

1. International Diabetes Federation. (n.d.) About diabetes. Available at: https://idf.org/about diabetes/what is-diabetes/ (Accessed: 5 September 2024)

2. International Diabetes Federation. (n.d.) Type 1 diabetes. Available at: https://idf.org/about diabetes/type-1 diabetes/ (Accessed: 5 September 2024)

3. World Health Organization. (n.d.). Health topics Diabetes. Available at: https://www.who.int/health topics/ diabetes#tab=tab_1 (Accessed: 5 September 2024)

4. World Health Organization. (n.d.). Fact Sheets Diabetes. Available at: https://www.who.int/news-room/fact-sheets/ detail/diabetes (Accessed: 5 September 2024)

5. American Diabetes Association. (n.d.) About Diabetes. Understanding Type 1 Diabetes. Available at: https:// diabetes.org/about-diabetes/type-1 (Accessed: 5 September 2024)

6. International Diabetes Federation. (n.d.) Type 2 diabetes. Available at: https://idf.org/about-diabetes/type-2-diabetes/ (Accessed: 5 September 2024)

7. National Institute of Diabetes and Digestive and Kidney Diseases. (n.d.) Symptoms & Causes of Diabetes. Available at: https://www.niddk.nih.gov/health-information/diabetes/ overview/symptoms-causes(Accessed: 5 September 2024)

8. Centers for Disease Control and Prevention. (n.d.) Symptoms of Diabetes. Available at: https://www.cdc.gov/diabetes/signs symptoms/index.html (Accessed: 5 September 2024)

9. National Institute for Health and Care Excellence. (17 August 22) Type 1 diabetes in adults: diagnosis and management. Available at: https://www.nice.org.uk/guidance/ng17 (Accessed: 5 September 2024)

10. National Institute for Health and Care Excellence. (23 July 2008) Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus. Available at: https:// www.nice.org.uk/guidance/ta151/chapter/1-Recommendations (Accessed: 5 September 2024)

11. Convatec Group Plc Annual Report and Accounts 2022, p. 12 [pdf] Available at: https://www.convatecgroup.com/ globalassets/global assets/pdf/ convatec_ar2022__interactive.pdf. (Accessed: 5 September 2024)

 

You are leaving convatec.com

This Internet site may provide links or references to other sites but Convatec have no responsibility for the content of such other sites and shall not be liable for any damages or injury arising from that content. Any links to other sites are provided as merely a convenience to the users of this Internet site.

Do you wish to continue?